Improve Efficiency of Variant Screening for Biological Drugs
02 May 2013

In order to control the manufacturing of biological drugs efficiently, it is necessary to understand their physicochemical properties in the early stages and identify the important quality attributes. The need for screening multiple variants early in the process leads to an increased workload.

High resolution mass spectrometry is a useful tool to assess important attributes of those variants such as intact mass, termini sequences and glycosylation profile.

Software is available to automate these analyses and subsequent data processing thereby reducing the workload and increasing confidence in the results by minimizing manual steps.

Attend this webinar to discover:
•Methods to automate the analysis of intact and subunit level of therapeutic monoclonal antibodies
•Tools for rapid N- and C- terminal sequencing of biologic drugs
•Automated glycoprofiling and glycan analysis at the glycopeptide level

Bruker Daltonics

Show    per page
1 of 9 Page     1 2 3  ... Next 
Light Sheet Imaging for Fast 3D Live Cell and Tissue Imaging26 Feb 2015Read
A New Approach for Color Quality Control in Whole Slide Imaging Systems12 Feb 2015Read
Strategies for the Separation and Characterization of Protein Biopharmaceuticals28 Jan 2015Read
Simultaneous Quantitative Determination and Screening of Pesticides in Fruits and Vegetables using LC-Q-Orbitrap-MS10 Dec 2014Read
Nanoparticle size characterization: Tips and Tricks8 Dec 2014Read
Sprint Bioscience on label-free fragment screening8 Dec 2014Read
Imaging Masterclass 3: Static vs. Dynamic Image Analysis8 Dec 2014Read
Laser Diffraction Masterclass 58 Dec 2014Read
How to characterize and optimize inkjet inks Part 38 Dec 2014Read
Exploring OMICS in 3D Microtissues4 Dec 2014Read